FIGURE
Fig. 3
- ID
- ZDB-FIG-220927-37
- Publication
- Brinza et al., 2022 - Sweroside Ameliorated Memory Deficits in Scopolamine-Induced Zebrafish (Danio rerio) Model: Involvement of Cholinergic System and Brain Oxidative Stress
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. 3
Evaluation of recognition memory in Sco-treated zebrafish subjected to sweroside treatment at doses of 2.79, 8.35, and 13.95 nM in the NOR test: (A) Representative tracking locomotion patterns in various groups; (B) Preference (%). Data are presented as means ± S.E.M. (n = 10 animals per group). *** p < 0.0001 and **** p < 0.00001 (Tukey?s post hoc analyses). Galantamine (GAL, 2.71 ?M) was used as reference positive drug. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
| Fish: | |
|---|---|
| Conditions: | |
| Observed In: | |
| Stage: | Adult |
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Molecules